InMed Pharmaceuticals (INM) Receivables - Net (2021 - 2025)
Historic Receivables - Net for InMed Pharmaceuticals (INM) over the last 5 years, with Q4 2025 value amounting to $182967.0.
- InMed Pharmaceuticals' Receivables - Net fell 3031.66% to $182967.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $182967.0, marking a year-over-year decrease of 3031.66%. This contributed to the annual value of $465104.0 for FY2025, which is 124035.73% up from last year.
- According to the latest figures from Q4 2025, InMed Pharmaceuticals' Receivables - Net is $182967.0, which was down 3031.66% from $343469.0 recorded in Q3 2025.
- Over the past 5 years, InMed Pharmaceuticals' Receivables - Net peaked at $465104.0 during Q2 2025, and registered a low of $14842.0 during Q3 2021.
- Over the past 5 years, InMed Pharmaceuticals' median Receivables - Net value was $84837.0 (recorded in 2022), while the average stood at $157786.9.
- Per our database at Business Quant, InMed Pharmaceuticals' Receivables - Net crashed by 4803.44% in 2024 and then surged by 124035.73% in 2025.
- Quarter analysis of 5 years shows InMed Pharmaceuticals' Receivables - Net stood at $50304.0 in 2021, then soared by 62.31% to $81647.0 in 2022, then fell by 18.21% to $66775.0 in 2023, then soared by 293.21% to $262569.0 in 2024, then crashed by 30.32% to $182967.0 in 2025.
- Its last three reported values are $182967.0 in Q4 2025, $343469.0 for Q3 2025, and $465104.0 during Q2 2025.